Holen Sie sich die Stockscreener-App
16.51
2.54%
-0.4308
Handel nachbörslich:
16.32
-0.1882
-1.14%
Schlusskurs vom Vortag:
$16.94
Offen:
$16.94
24-Stunden-Volumen:
29,557
Relative Volume:
3.09
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+11.66%
1M Leistung:
+8.16%
6M Leistung:
+29.68%
1J Leistung:
+58.73%
1-Tages-Spanne:
$16.19
$16.94
1-Wochen-Bereich:
$14.70
$16.99
52-Wochen-Spanne:
$7.14
$16.99
Advisorshares Psychedelics Etf Stock (PSIL) Company Profile
Firmenname
Advisorshares Psychedelics Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PSIL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PSIL
Advisorshares Psychedelics Etf
|
16.51 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
309.80 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
628.86 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
631.74 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
244.81 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
561.25 | 124.43B | 0 | 0 | 0 | 0.00 |
Advisorshares Psychedelics Etf Aktie (PSIL) Neueste Nachrichten
(PSIL) Proactive Strategies - news.stocktradersdaily.com
Don't Trip. These Psychedelic Stocks May Have Some Life in Them Yet - US News Money
(PSIL) Investment Analysis - news.stocktradersdaily.com
5 ETFs That Beat the Market in the First Half of 2025 - Zacks Investment Research
(PSIL) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors - Benzinga
Worst Thematic ETFs of 2021: How are they faring today? - Trackinsight
(PSIL) Trading Report - news.stocktradersdaily.com
Where are the Opportunities in (PSIL) - news.stocktradersdaily.com
The Zacks Analyst Blog Highlights SGDM, SLVP, SHLD, COPJ and PSIL - Zacks Investment Research
5 Sector ETFs That Have Outperformed the S&P 500 in Q1 - TradingView
AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Trading Down 0.2% – What’s Next? - Defense World
(PSIL) Investment Analysis and Advice - news.stocktradersdaily.com
Best Mushroom Stocks: Top Picks, Pros and Cons - timothysykes.com
Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF - ACCESS Newswire
TheStreet Pro - TheStreet
5 Best-Performing Sector ETFs Halfway Through Q1 - MSN
Psychedelic Funding, Public Markets, and M&A in 2024 - Psychedelic Alpha
When the Price of (PSIL) Talks, People Listen - Stock Traders Daily
Psychedelic ETF PSIL Is 2025's Best-Performing ETF - etf.com
5 ETFs That Beat Market Turmoil With Gains Last Week - Benzinga
5 Best-Performing Sector ETFs of Volatile January - MSN
High-Momentum ETFs Leading the Market This Year - MarketBeat
Shares Soar as GH Research Unveils Promising Drug Trial - Value The Markets
5 Best-Performing ETFs of January - Yahoo Finance
Under-The-Radar Opportunities In ETFs - Seeking Alpha
Under-the-Radar Opportunities in ETFs - ETF Trends
AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Stock Price Down 1.2% – What’s Next? - Defense World
CT Private Equity Trust (LON:CTPE) Trading 1.2% Higher – Here’s What Happened - Defense World
(PSIL) Trading Advice - Stock Traders Daily
Objective long/short (PSIL) Report - Stock Traders Daily
5 Best-Performing Sector ETFs of Q4 - Nasdaq
(PSIL) Technical Data - Stock Traders Daily
AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Trading Down 0.8% – Time to Sell? - Defense World
Why Is Penny Stock Clearmind Gaining Today? - Benzinga
EMIF, PSIL: 2 ETFs with Over 20% Upside Potential, According to Analysts - TipRanks
Vaccine Stocks Slide, Psychedelic Stocks Surge After RFK Jr. HHS Nomination - Barchart.com
No Trippin’: Trump Trade Pushes PSIL, VCAR Higher - Yahoo Finance
5 Best-Performing ETFs of October - Yahoo Finance
DRUG Enhances Buzz for Psilocybin, Psychedelic ETFs - ETF.com
Reverse split for AdvisorShares Psychedelic ETF starts today - Crain's Chicago Business
ADVISORSHARES PSYCHEDELICS ETF To Carry Out 1-for-10 Reverse Stock Split On September 10th, 2024 - 富途牛牛
AdvisorShares Announces Reverse Split of ETF - Stock Titan
Best Psychedelic ETFs - Benzinga
Losing Ones Sense of Self – How Psilocybin Breakthroughs Could Spark Fresh Investments - Securities.io
Top and Flop ETFs of the First Half - Yahoo Finance
Best and Worst ETF Zones of Q2 - Nasdaq
LSD, Ecstasy Lure Traders Betting on ‘Psychedelic Renaissance’ - Bloomberg
Psychedelic Funding & Public Markets in 2023 - Psychedelic Alpha
Psychedelics Are Going Mainstream. Investing in Them Hasn’t. - WSJ
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More - Benzinga
Finanzdaten der Advisorshares Psychedelics Etf-Aktie (PSIL)
Es liegen keine Finanzdaten für Advisorshares Psychedelics Etf (PSIL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.81%
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):